Skip to main content

Basic Research on cognitive impairments in Noonan Syndrome: the NMDA-D1 receptor complex as a novel/pharmacological target for the management of these disabilities

Durata del progetto: 24 mesi

Contributo assegnato: Euro 118.800,00